3.4.24.61: nardilysin
This is an abbreviated version!
For detailed information about nardilysin, go to the full flat file.
Word Map on EC 3.4.24.61
-
3.4.24.61
-
metalloendopeptidase
-
ectodomain
-
heparin-binding
-
pitrilysins
-
adam17
-
hb-egf
-
insulysin
-
insulinase
-
hxxeh
-
dynorphins
-
medicine
- 3.4.24.61
- metalloendopeptidase
- ectodomain
-
heparin-binding
- pitrilysins
- adam17
- hb-egf
- insulysin
- insulinase
-
hxxeh
- dynorphins
- medicine
Reaction
hydrolysis of polypeptides, preferably at -Xaa-/-Arg-Lys-, and less commonly at -Arg-/-Arg-Xaa-, in which Xaa is not Arg or Lys =
Synonyms
hNRDc1, MGE, miniglucagon-generating endopeptidase, More, N-arginine dibasic (NRD) convertase, N-Arginine dibasic convertase, nardilysin, nardilysin (V8), nardilysin convertase, NRD convertase, NRD-convertase, Nrd1, Nrd1 and NRDc, NRDc
ECTree
Advanced search results
Application
Application on EC 3.4.24.61 - nardilysin
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
medicine
medicine
rising serum nardilysin concentrations following malignant cerebral infarction are strongly related to stroke severity, inflammatory extent and a higher risk of mortality, substantializing serum nardilysin is a potential prognostic biomarker for malignant cerebral infarction
medicine
serum nardilysin has potential as a novel prognostic biomarker for intrahepatic cholangiocarcinoma, which may reflect epithelial-mesenchymal transition features in primary tumor regions. It is proposed that the preoperative evaluation of serum nardilysin is a potential clinical tool for predicting tumor recurrence in and the overall prognosis of patients after curative-intent surgery